Orgenesis Q2 EPS $0.23 Down From $0.76 YoY, Sales $246.00K Up From $113.00K YoY
Portfolio Pulse from Benzinga Newsdesk
Orgenesis (NASDAQ:ORGS) reported Q2 earnings per share (EPS) of $0.23, a 69.74% decrease from $0.76 YoY. However, sales increased by 117.70% to $246,000 from $113,000 YoY.
August 08, 2024 | 9:26 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Orgenesis reported a significant drop in Q2 EPS by 69.74% to $0.23, while sales increased by 117.70% to $246,000. The mixed results may lead to short-term volatility in the stock price.
The significant decrease in EPS is a negative indicator, but the substantial increase in sales is a positive sign. These mixed results are likely to cause short-term volatility in the stock price as investors digest the contrasting metrics.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100